allison m glasser - Public Health

Author Information

Allison M. Glasser is a researcher affiliated with The Schroeder Institute for Tobacco Research and Policy Studies at Truth Initiative in Washington, DC, USA. Her work primarily focuses on public health, with a specific emphasis on tobacco research and policy studies. Her research contributes significantly to understanding tobacco use patterns, particularly among vulnerable populations such as youth and individuals experiencing homelessness.

Research Contributions

Allison M. Glasser has made substantial contributions to the field of public health through her research on tobacco and marijuana use. Her work often examines the complex interplay between tobacco product types, user demographics, and socio-environmental factors. Notable studies include exploring the use of tobacco and marijuana among youth experiencing homelessness and the effects of health warnings and risk claims on young adult smokers. Her research also delves into the disparities in tobacco retailer density and their impact on tobacco use, as well as the public health implications of regulatory decisions like those of the FDA regarding IQOS. Through her studies, Glasser has provided valuable insights into tobacco dependence, risk perceptions, and control strategies.

Aliases

Allison M. Glasser is also known by the aliases "Allison Glasser" and "Allison M Glasser." These variations are used interchangeably in various publications and references.

Publication and Citation Metrics

Metric	Value
Total Citations	1950
H-index	20
Total Papers	55

Publications:

Characterizing tobacco and marijuana use among youth combustible tobacco users experiencing homelessness – considering product type, brand, flavor, frequency, and higher-risk use patterns and predictors

DOI: 10.1186/s12889-022-13244-3

Year: 2022

Effects of IQOS health warnings and modified risk claims among young adult cigarette smokers and non-smokers

DOI: 10.1136/tobaccocontrol-2021-056810

Year: 2021

Validation of the Wave 1 and Wave 2 Population Assessment of Tobacco and Health (PATH) Study Indicators of Tobacco Dependence Using Biomarkers of Nicotine Exposure Across Tobacco Products.

DOI: 10.1093/ntr/ntab162

Year: 2021

Associations between disparities in tobacco retailer density and disparities in tobacco use.

DOI: 10.1016/j.ypmed.2021.106910

Year: 2021

Characterizing Tobacco and Marijuana Use Among Youth Experiencing Homelessness in a Midwestern City

DOI: 10.21203/rs.3.rs-824818/v1

Year: 2021

"I smoked that cigarette, and it calmed me down": A qualitative analysis of intrapersonal, social, and environmental factors influencing decisions to smoke among youth experiencing homelessness.

DOI: 10.1093/ntr/ntab196

Year: 2021

Retailer density reduction approaches to tobacco control: A review.

DOI: 10.1016/j.healthplace.2020.102342

Year: 2021

The Public Health Standard in Action-Analysis of the US Food and Drug Administration's IQOS Review.

DOI: 10.1001/jamaoncol.2020.3316

Year: 2020

Youth Vaping and Tobacco Use in Context in the United States: Results from the 2018 National Youth Tobacco Survey.

DOI: 10.1093/ntr/ntaa010

Year: 2020

Perceptions of Use Patterns and Health Consequences Associated With Mentholated Cigarettes Among U.S. Adults

DOI: 10.1177/1090198119897608

Year: 2020

How Can Stakeholder Engagement Improve HTA?

What are the challenges faced by WHO?

What Are the Key Provisions of HIPAA?

Why is Public Health Important?

Why is stakeholder involvement important?

How Are COVID-19 Vaccines Distributed?

What is Public Health?

Where Can I Get the COVID-19 Vaccine?

What is Hand Hygiene?

What is Healthcare Policy?

Partnered Content Networks

Relevant Topics